Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load
Open Access
- 1 June 2004
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 9 (6), 902-913
- https://doi.org/10.1016/j.ymthe.2004.03.005
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Antisense-Mediated Inhibition of Human Immunodeficiency Virus (HIV) Replication by Use of an HIV Type 1-Based Vector Results in Severely Attenuated Mutants Incapable of Developing ResistanceJournal of Virology, 2004
- In Vivo Selection for Human and Murine Hematopoietic Cells Transduced with a Therapeutic MGMT Lentiviral Vector that Inhibits HIV ReplicationMolecular Therapy, 2004
- A bicistronic SIN-lentiviral vector containing G156A MGMT allows selection and metabolic correction of hematopoietic protoporphyric cell linesThe Journal of Gene Medicine, 2003
- Management of the Adverse Effects of Antiretroviral Therapy and Medication AdherenceClinical Infectious Diseases, 2000
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997
- Antiviral Effect and Ex Vivo CD4 + T Cell Proliferation in HIV-Positive Patients as a Result of CD28 CostimulationScience, 1996
- Gene Therapy for Human Immunodeficiency Virus Infection: Genetic Antiviral Strategies and Targets for InterventionHuman Gene Therapy, 1994
- Gene Therapy: A Bold Direction for HIV-1 Treatment*AIDS Research and Human Retroviruses, 1993
- HIV-1 Gag mutants can dominantly interfere with the replication of the wild-type virusCell, 1989
- Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies.BMJ, 1987